Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 146.06
-3.34 %
$ 19.3 B
Market Cap
-59.62
P/E
BALANCE SHEET
1.44 B
ASSETS
676 M
LIABILITIES
765 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Natera, Inc.
| Current Assets | 1.26 B |
| Cash & Short-Term Investments | 879 M |
| Receivables | 278 M |
| Other Current Assets | 101 M |
| Non-Current Assets | 183 M |
| Long-Term Investments | 0 |
| PP&E | 168 M |
| Other Non-Current Assets | 15.4 M |
| Current Liabilities | 307 M |
| Accounts Payable | 15 M |
| Short-Term Debt | 92 M |
| Other Current Liabilities | 200 M |
| Non-Current Liabilities | 369 M |
| Long-Term Debt | 350 M |
| Other Non-Current Liabilities | 19.1 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Cash & Cash Equivalents | 642.1 | 466.0 | 84.4 | 48.7 | 61.9 | 46.4 | 12.6 | 15.3 | 28.9 | 87.2 | 30.5 | 5.7 |
| Short Term Investments | 236.9 | 432.3 | 829.9 | 688.6 | 379.1 | 107.5 | 106.2 | 130.9 | 201.6 | 0 | 0 | 0 |
| Receivables | 278.3 | 244.4 | 122.1 | 78.6 | 53.4 | 62.2 | 44.1 | 13.4 | 5.9 | 5.9 | 6.6 | 1.3 |
| Inventory | 40.8 | 35.4 | 26.9 | 20.0 | 12.4 | 13.6 | 9.0 | 6.4 | 8.1 | 11.5 | 10.7 | 1.6 |
| Other Current Assets | 60.5 | 33.6 | 29.9 | 26.8 | 16.4 | 10.8 | 8.7 | 8.2 | 6.2 | 1.8 | 1.3 | 0.4 |
| Total Current Assets | 1 258.5 | 1 211.8 | 1 093.1 | 862.7 | 523.2 | 240.5 | 144.8 | 174.1 | 250.7 | 106.5 | 49.1 | 9.0 |
| PP&E | 167.7 | 164.3 | 124.5 | 54.7 | 47.0 | 24.3 | 29.7 | 32.3 | 12.7 | 14.6 | 9.8 | 4.1 |
| Intangible Assets | 0 | 0 | 2.3 | 1.7 | 1.2 | 1.7 | 2.6 | 1.3 | 0.8 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | (18.2) | (27.4) | (8.4) | 0 | 0.3 | 0.3 | 0.7 | 0 | 0 | 0 |
| Other Long Term Assets | 15.4 | (1.7) | 18.8 | 14.7 | 12.5 | 1.6 | 4.3 | 4.3 | 1.8 | 2.6 | 0.8 | (4.1) |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 K |
| Total Assets | 1 441.7 | 1 394.5 | 1 236.5 | 932.2 | 582.7 | 268.2 | 178.8 | 210.7 | 265.2 | 123.6 | 59.7 | 13.1 |
| LIABILITIES | ||||||||||||
| Accounts Payable | 15.0 | 31.1 | 27.2 | 8.1 | 8.6 | 14.6 | 8.5 | 11.5 | 7.3 | 8.9 | 11.3 | 4.5 |
| Short Term Debt | 92.0 | 88.0 | 55.8 | 57.4 | 55.9 | 50.2 | 50.1 | 49.6 | 42.1 | 2.3 | 1.8 | 0 |
| Other Current Liabilities | 196.5 | 176.3 | 126.3 | 81.8 | 57.7 | 43.9 | 45.0 | 34.3 | 30.6 | 18.2 | 10.2 | 134.4 |
| Total Current Liabilities | 307.3 | 310.5 | 219.0 | 199.1 | 179.9 | 114.0 | 105.5 | 96.4 | 80.5 | 29.9 | 23.6 | 138.9 |
| Long Term Debt | 350.0 | 358.2 | 341.4 | 223.7 | 100.0 | 73.4 | 73.1 | 0 | 0 | 24.5 | 22.5 | 0 |
| Deferred Tax Income | 0 | 20.1 | 15.9 | 25.7 | 7.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 1.5 | 0.3 | 0.3 | 8.6 | 10.6 | 7.8 | 0 | 240.6 | 185.2 | 0 |
| Total Liabilities | 676.4 | 688.7 | 583.2 | 445.9 | 303.9 | 236.0 | 189.1 | 104.2 | 80.5 | 295.0 | 231.2 | 138.9 |
| EQUITY | ||||||||||||
| Common Stock | 11 K | 11 K | 10 K | 9 K | 8 K | 7 K | 6 K | 5 K | 5 K | 1 K | 1 K | 1 K |
| Retained Earnings | (2 377.4) | (1 942.6) | (1 394.8) | (929.3) | (699.2) | (574.5) | (482.2) | (345.8) | (250.1) | (179.8) | (174.7) | (137.5) |
| Other Accumulative Comprehensive Income/Loss | (3.1) | (16.4) | (2.3) | 4.3 | 0.9 | (0.6) | (0.8) | (0.7) | (1.4) | (9.6) | (4.4) | 0 |
| Total Equity | 765.3 | 705.7 | 653.3 | 486.2 | 278.7 | 32.2 | (10.4) | 106.5 | 184.8 | (171.3) | (171.5) | (125.8) |
| Total Liabilities and Equity | 1 441.7 | 1 394.5 | 1 236.5 | 932.2 | 582.7 | 268.2 | 178.8 | 210.7 | 265.2 | 123.6 | 59.7 | 0 |
| SHARES OUTSTANDING | ||||||||||||
| Common Shares Outstanding | 115.0 | 98.4 | 90.6 | 81.0 | 69.6 | 57.7 | 53.3 | 51.4 | 26.2 | 36.7 | 36.7 | 3.1 |